Key terms
About ARMP
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ARMP news
Mar 25
6:46am ET
Buy Rating Affirmed for Armata Pharmaceuticals Amid Progress in Bacteriophage Therapy Development
Mar 23
2:00am ET
Armata Pharmaceuticals Under Pressure: Navigating the Risks as Cost-Cutting Measures Threaten Revenue
Mar 22
6:17am ET
Buy Rating Affirmed for Armata Pharmaceuticals Amid Clinical Progress and Strategic Growth
Mar 21
4:08pm ET
Armata Pharmaceuticals reports Q4 EPS (55c) vs. (29c) last year
No recent press releases are available for ARMP
ARMP Financials
Key terms
Ad Feedback
ARMP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ARMP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range